Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Decitabine, Vorinostat, and Cytarabine in Acute Myeloid Leukemia

NCT01130506 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01130506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Decitabine, Vorinostat, and Cytarabine in Acute Myeloid Leukemia
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
May 17, 2010
Completion date
Not reported
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

previously treated myelodysplastic syndrome, recurrent adult acute myeloid leukemia, refractory acute myeloid leukemia, secondary acute myeloid leukemia, therapy-related acute myeloid leukemia, untreated adult acute myeloid leukemia